Obserwuj
Meredith Juncker, PhD
Meredith Juncker, PhD
Dana-Farber Cancer Institute
Zweryfikowany adres z dfci.harvard.edu
Tytuł
Cytowane przez
Cytowane przez
Rok
ISG15 and ISGylation in human diseases
O Mirzalieva, M Juncker, J Schwartzenburg, S Desai
Cells 11 (3), 538, 2022
682022
Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases
S Desai, M Juncker, C Kim
Experimental biology and medicine 243 (6), 554-562, 2018
382018
ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondria in Ataxia Telangiectasia cells
M Juncker, C Kim, R Reed, A Haas, J Schwartzenburg, S Desai
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (6), 166102, 2021
222021
Increased ISGylation in cases of TBI-exposed ALS veterans
J Schwartzenburg, M Juncker, R Reed, S Desai
Journal of Neuropathology & Experimental Neurology 78 (3), 209-218, 2019
172019
SUMOylation of mitofusins: a potential mechanism for perinuclear mitochondrial congression in cells treated with mitochondrial stressors
C Kim, M Juncker, R Reed, A Haas, J Guidry, M Matunis, WC Yang, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (6), 166104, 2021
132021
Evidence for the Deregulation of Protein Turnover Pathways in Atm-Deficient Mouse Cerebellum: An Organotypic Study
CD Kim, RE Reed, MA Juncker, Z Fang, SD Desai
Journal of Neuropatholgy & Experimental Neurology 76 (7), 578-584, 2017
132017
ISG15 Attenuates Mitophagy in Ataxia-Telangiectasia
MA Juncker
Louisiana State University Health Sciences Center, 2020
12020
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–7